Over 700 Pharma & Biotech players across Asia and beyond to gather in Singapore

18 FEB 2019 – Returning on 18- 20 March 2019 after a successful 2018 debut, Phar-East will once again bring together experts from Asian pharma & biotechs, big pharma, regulators, payers, technology innovators and more to share their expertise and chart Asia’s path forward. The 2019 edition will bring over 120 expert speakers sharing on the latest trends and developments on 6 key themes: Immunotherapy, Pharma 4.0, Regulatory Affairs, Market Access and brand new for 2019, Clinical Trials and Biotech Investment
The conference will open with a keynote session with Sir David Lane, Chief Scientist, A*STAR, Singapore on the topic of Going global and keeping it local: Is biotech innovation sustainable in Asia? Sir David Lane is one of the key scientists credited on the discovery of cancer gene p53, a gene which mutation cause near 50% of all human cancer. He will share his view on how biomedical sciences have developed in Singapore, Japan and the remaining APAC region, and prospects for Asian biotech and pharma industry.

After which Byung-Geon (BG) Rhee, CEO, SCM Lifesciences, Chairman, Council for Advanced Regenerative Medicine, Former President, Green Cross Corporation, South Korea will share more on the topic of Integrating Asia into the global era of innovative medicine.

There will also be an interesting keynote panel on Pharma Trends: Women health as the next focus with the following expert speakers:

• Reenita Das, Partner, Frost & Sullivan, USA

• Evelyn Pang, Head of Operations, Sanofi Pasteur, Singapore
• Marcel van Duin, Vice President, Therapeutic Area Head Reproductive Health & Endocrinology Research, Ferring Pharmaceuticals, Netherlands

Held from 19 – 20 March in Resorts World Convention Centre, Singapore, the conference will bring over 120 expert speakers. Here’s a sample of them:
• Aung Myo, Vice President, Clinical Development, Tessa Therapeutics, Singapore
• Jun Feng, Market Access Associate Director – Oncology, JAPAC, AbbVie, Singapore
• Hyejin Shin, Director, Group Leader, Clinical QA, Samsung Bioepis, South Korea
• Enver Erkan, Country Manager, Pfizer, Singapore
• Philippe Pinton, Regional Head, Specialty Therapy, Takeda, Japan
• Shailendra Bajpai, Global Head of Disease Management, Sanofi, Singapore
• Robert Yu, Senior Vice President, Operations, Yuyu Pharma, South Korea

See full speakers list here: www.terrapinn.com/exhibition/phar-east/speakers.stm

In addition to the main conference, a pre-conference day will be held on 18th March featuring the following workshops:
1. Biotech Bootcamp Workshop
2. Workshop on Clinical Trial and Issues Management – Skills for Effective Solutions by Workshop leader: Maggie Lim, Director, Clinical Quality Assurance, Pharma R&D, APAC, Global Quality Assurance, R&D Chief Regulatory Office, GSK, Singapore
3. Workshop on the topic of: “Digital Transformation in Clinical trials: AI, Machine Learning & The Medidata Platform – Sponsored by Medidata
4. Site Tour to Experimental Therapeutics Centre (ETC), Singapore Bioimaging Consortium (SBIC), Institute of Medical Biology (IMB) and Genome Institute of Singapore (GIS)

The 3-day event will bring over 700 attendees and 40+ sponsors and exhibitors.

Find out more at: http://www.terrapinn.com/exhibition/phar-east/index.stm

About Phar-East 2018
Conference: 19 – 20 March 2019
Pre-conference day: 18 March 2019

Conference opening hours: 08:45 am
Venue: Resorts World Convention Centre, Compass Ballroom, Basement 2
Website: http://www.terrapinn.com/exhibition/phar-east/index.stm

Leave a Reply

Your email address will not be published. Required fields are marked *